(Q36592698)

English

Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study

scientific article published on 23 November 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

amoxicillin/clavulanic acid

1 reference

based on heuristic

inferred from title

piperacillin/tazobactam

1 reference

based on heuristic

inferred from title

author name string

N C Schaper

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

M Dryden

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

P Kujath

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

D Nathwani

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

P Arvis

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

P Reimnitz

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J Alder

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

I C Gyssens

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

publication date

23 November 2012

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

41

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

175-186

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

23 November 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

9 September 2017

Diabetic foot infection: a critical review of recent randomized clinical trials on antibiotic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

9 September 2017

Meta-analysis of trials evaluating parenteral antimicrobial therapy for skin and soft tissue infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

9 September 2017

Therapeutic options for diabetic foot infections: a review with an emphasis on tissue penetration characteristics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

9 September 2017

The treatment of diabetic foot infections: focus on ertapenem

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

9 September 2017

Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

9 September 2017

Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

9 September 2017

Clinical management of diabetic foot infection: diagnostics, therapeutics and the future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

9 September 2017

Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

9 September 2017

Diagnosis and treatment of diabetic foot infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

9 September 2017

Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

9 September 2017

Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

9 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

20 September 2018

Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

9 September 2017

Effects of macro- and microcirculatory functions on ceftriaxone concentrations in tissues of patients with stage IV peripheral arterial occlusive disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

9 September 2017

In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

30 September 2017

Penetration of moxifloxacin into peripheral compartments in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

30 September 2017

Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

30 September 2017

Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

28 June 2018

Classification of diabetic foot wounds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

28 June 2018

Factors affecting gentamicin penetration in lower extremity ischemic tissues with ulcers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

20 September 2018

Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

20 September 2018

Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

20 September 2018

A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

20 September 2018

Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

20 September 2018

An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

20 September 2018

Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5-year follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

20 September 2018

A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

20 September 2018

Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

20 September 2018

The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3566391

20 September 2018

Risk Factors for Foot Infections in Individuals With Diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0367-X

21 January 2018

Validation of the Infectious Diseases Society of America's Diabetic Foot Infection Classification System

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0367-X

21 January 2018

Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin–clavulanate

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0367-X

21 January 2018

The dysvascular foot: a system for diagnosis and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/23180507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23180507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diabetic foot

1 reference

https://pubmed.ncbi.nlm.nih.gov/23180507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preemptive Isolation to Prevent Methicillin-Resistant Staphylococcus aureus Cross-Transmission in Diabetic Foot

1 reference

https://pubmed.ncbi.nlm.nih.gov/23180507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Procalcitonin as a diagnostic aid in diabetic foot infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/23180507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/23180507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of vacuum-assisted closure (VAC) therapy in the healing of chronic diabetic foot ulcers

1 reference

https://pubmed.ncbi.nlm.nih.gov/23180507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical Therapy of Diabetic Foot Infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/23180507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of diabetic foot infections in an era of increasing microbial resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/23180507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/23180507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S15010-012-0367-X

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

release_wh25j6hx65ew7jcduiaihplz3m

1 reference

https://api.fatcat.wiki/v0/release/wh25j6hx65ew7jcduiaihplz3m

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36592698&oldid=2199070066"